The CDKN2B-AS1/miR-98-5p axis plays an essential role in the occurrence and progression of NPC, it is may be a treatment target and prognostic marker for patients with NPC (Li et al. 2021). This evidence concerns the gene CDKN2B and nasopharyngeal carcinoma.